Skip to main content
SpringerLink
Log in

Considerations of Traditional Chinese Medicine as Adjunct Therapy in the Management of Ulcerative Colitis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Ulcerative colitis (UC) has been treated with traditional Chinese medicine (TCM) for literally thousands of years. This paper gives an overview of TCM in the management of UC, provides an account of the state of the evidence, identifies gaps in the research base, and makes recommendations for future research. TCM is based on patterns and this influences the selection of the type of herbal medication or manipulation technique used for treatment. The majority of clinical studies on the efficacy of Chinese herbal medicine and acupuncture in the treatment of UC have methodological shortcomings. The extent of heterogeneity in many of these clinical trials, poor design quality of past studies prevent meaningful systematic reviews (SRs) or meta-analysis, although there are positive signs that TCM may be useful in relieving abdominal pain and reducing inflammation. Many unknowns still exist, including the active ingredients within Chinese herbal medicine and the potential for interaction with other drugs or western medications. While there may be a potential role for utilizing TCM in the treatment of UC patients relying on both traditional concepts and modern developments, it should be recognized that there are no studies that irrefutably support the use of TCM in the treatment of UC. Further basic or translational research must be done to elucidate mechanisms of action of these agents, and well-designed and well-conducted clinical studies must also be done to determine efficacy and safety of these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CAM:

Complementary and alternative medicine

CBM:

Chinese biomedical literature database

CHM:

Chinese herbal medicine

EBM:

Evidence-based medicine

IM:

Integrative medicine

PCM:

Proprietary Chinese medicine

PRISMA:

Preferred reporting items for systematic reviews and meta-analyses

RCT:

Randomized controlled trial

SR:

Systematic review

TCM:

Traditional Chinese medicine

UC:

Ulcerative colitis

References

  1. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641–1657

    PubMed  CAS  Google Scholar 

  2. Farrell RJ, Peppercorn M (2002) Ulcerative colitis. Lancet 359:331–340

    PubMed  Google Scholar 

  3. Kane SV (2006) Adherence issues in the treatment of ulcerative colitis. Aliment PharmacolTher 23:577–585

    CAS  Google Scholar 

  4. Gionchetti P, Rizzello F, Habal F, Morselli C, Amadini C, Romagnoli R et al (2003) Standard treatment of ulcerative colitis. Dig Dis 21:157–167

    PubMed  Google Scholar 

  5. Zhang Z, Kennedy H (2009) Ulcerative colitis: current medical therapy and strategies for improving medication adherence. Eur J GastroenterolHepatol 21:1–8

    Google Scholar 

  6. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429

    PubMed  CAS  Google Scholar 

  7. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463

    PubMed  CAS  Google Scholar 

  8. SubhutiDharmananda (2006) Autoimmune diseases and the potential role of Chinese herbal medicine. http://www.itmonline.org/arts/autoimmune.html (Accessed Jan 1, 2011)

  9. Langmead L, Rampton DS (2006) Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment PharmacolTher 23:341–349

    CAS  Google Scholar 

  10. Borchers AT, Hackman RM, Keen CL, Stern JS, Gershwin ME (1997) Complementary medicine: a review of immunomodulatory effects of Chinese herbal medicines. Am J ClinNutr 66:1303–1312

    CAS  Google Scholar 

  11. Clarke JO, Mullin GE (2008) A review of complementary and alternative approaches to immunomodulation. NutrClinPract 23:49–62

    Google Scholar 

  12. Rawsthorne P, Shanahan F, Cronin NC et al (1999) An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 94:1298–1303

    PubMed  CAS  Google Scholar 

  13. Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ (2005) Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 11:287–295

    PubMed  Google Scholar 

  14. Hartel U, Volger E (2004) Use and acceptance of classical natural and alternative medicine in Germany--findings of a representative population-based survey. ForschKomplementarmedKlassNaturheilkd 11:327–334

    CAS  Google Scholar 

  15. Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Tolia V, Bousvaros A (2002) Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 97:382–388

    PubMed  Google Scholar 

  16. Flaws B (2005) The treatment of modern western diseases with Chinese medicine. Blue Poppy Press, Boulder, pp 546–555

    Google Scholar 

  17. Lu YP (2009) The academic experience of professor Wang Changhong in treating ulcerative colitis. PLA Postgraduate Medical School, Beijing, pp 14–16

    Google Scholar 

  18. Zhang YH (2004) Study on the ancient literature of Changpi (Ulcerative colitis). Hebei Medical University, Shijiazhuang, pp 6–84

    Google Scholar 

  19. Zhang BY (1985) Chinese internal medicine. Shanghai Scientific and Technical Publishers, Shanghai, pp 1–298

    Google Scholar 

  20. Sutherland LR, Verhoef MJ (1994) Why do patients seek a second opinion or alternative medicine? J ClinGastroenterol 19:194–197

    CAS  Google Scholar 

  21. Richardson J (2004) What patients expect from complementary therapy: a qualitative study. Am J Public Health 94:1049–1053

    PubMed  Google Scholar 

  22. Hilsden RJ, Scott CM, Verhoef MJ (1998) Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 93:697–701

    PubMed  CAS  Google Scholar 

  23. Chen JT, Yang CB, Ke X (2007) Progress of Chinese medicine research treatment in ulcerative colitis. InfTradit Chin Med 24:7–10

    Google Scholar 

  24. Fruehauf H (1997) The Treatment of difficult and recalcitrant diseases with Chinese herbs. ITM, Portland, pp 1–242

    Google Scholar 

  25. Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B (2006) Use of complementary and alternative medicine in Germany—a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 22:6–19

    Google Scholar 

  26. Wang YY (1997) Internal medicine of traditional Chinese medicine. Shanghai Scientific and Technical Publishers, Shanghai, pp 1–388

    Google Scholar 

  27. Zhou ZY (2003) Internal medicine of traditional Chinese medicine. China Press of Traditional Chinese Medicine, Beijing, p 521

    Google Scholar 

  28. Yue H, Wang TF, Chen JM, Yang L, Zhao D, Zhao Y, Wu XY, Qu K, Yu LL, Zhao FC (2010) Modem literature of common syndromes and syndrome factors of ulcerative colitis. J Beijing Univ Tradis Chin Med 33:305–308

    Google Scholar 

  29. Wang XY, Tian DL (2007) Etiological and pathological characteristics of ulcerative colitis and TCM differentiation and treatment. J Beijing Univ Tradis Chin Med 30:554–556

    CAS  Google Scholar 

  30. Wang XM, Wu HJ, Liu HR, Zhu Y, Kou ST, Zhao C, Tan LY (2007) Review of etiology and pathogenesis of ulcerative colitis and acupoint selection in Traditional Chinese Medicine. Liaoning J Tradis Chin Med 34:891–893

    Google Scholar 

  31. China National Committee for Terms in Sciences and Technologies (2004) Chinese terms in traditional Chinese medicine and pharmacy. Science Press, Beijing, pp 1–463

    Google Scholar 

  32. Li ZJ (2008) International standard Chinese-English basic nomenclature of Chinese medicine. People’s Medical Publishing House, Beijing, pp 1–789

    Google Scholar 

  33. Xie ZF (2004) English translation of common terms in traditional Chinese medicine. China Press of Traditional Chinese Medicine, Beijing, pp 1–502

    Google Scholar 

  34. State Bureau of Technical and Quality Supervision (2006) Basic theory nomenclature of traditional Chinese medicine. Standards Press of China, Beijing, pp 1–238

    Google Scholar 

  35. Deng TT (1984) Diagnostics of traditional Chinese medicine. Shanghai Scientific and Technical Publishers, Shanghai, pp 1–205

    Google Scholar 

  36. Wang YQ (2004) Diagnostics of traditional Chinese medicine. China Press of Traditional Chinese Medicine, Beijing, pp 1–246

    Google Scholar 

  37. Branch of Gastrointestinal Diseases, China Association of Chinese Medicine (2010) Consensus on Chinese medical diagnosis and treatment of ulcerative colitis. China J Tradis Chin Med Pharm 5:891–894

    Google Scholar 

  38. Yao NL (2005) Differential diagnostics of symptoms in traditional Chinese medicine 2nd ed. People’s Medical Publishing House, Beijing, pp 1–857

    Google Scholar 

  39. State Bureau of Technical Supervision (1997) Clinical terminology of traditional Chinese medical diagnosis and treatment of syndromes. Standards Press of China, Beijing, pp 1–88

    Google Scholar 

  40. State Administration of Traditional Chinese Medicine (1994) Diagnostic and therapeutic effect evaluation criteria of diseases and syndromes in traditional Chinese medicine. Nanjing University Press, Nanjing, pp 1–218

    Google Scholar 

  41. Shi LF, Zhu XX (2010) The progress of Chinese medicine treatment of ulcerative colitis. Chin Archives Tradis Chin Med 28:1871–1873

    Google Scholar 

  42. Shen H (2006) Several characteristics of drugs use of treating ulcerative colitis. Jiangsu J Tradis Chin Med 21:15–16

    Google Scholar 

  43. Sun CM, Zhang Y (2009) The preferred drug of traditional Chinese medicine and western treatment for ulcerative colitis. Med Innov China 6:152

    Google Scholar 

  44. Yang ZF, Guo WB, Fu JP (2001) Progress of traditional Chinese medications for ulcerative colitis. Chin Pharm J 16:8–9

    CAS  Google Scholar 

  45. Zhao MQ, Yin RL (2010) Application and development of Traditional Chinese medicine preparation in the treatment of ulcerative colitis. http://www.paper.edu.cn/index.php/default/releasepaper/content/201012-872(Accessed Apr 6, 2011)

  46. Tan FY, Zhuang ZQ (1998) An overview of drug retention enema methods in treating ulcerative colitis of Chinese herbal medicine. Chin J Integr Med 18:381–382

    CAS  Google Scholar 

  47. Kang J, Chan ZW (2002) Study overview and progress on drug retention enema methods in treating ulcerative colitis based on integration of traditional and western medicine. Central Plains Med J 29:38–39

    Google Scholar 

  48. Wang B, Ren S, Feng W, Zhong Z, Qin C (1997) Kuijieqing in the treatment of chronic non-specific ulcerative colitis. J Tradis Chin Med 17:10–13

    CAS  Google Scholar 

  49. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Shang RL, Qi F (2003) Houttuynia (yuxingcao) in the treatment of ulcerative colitis. World Chin J Digestol 11:1207–1210

    Google Scholar 

  50. Yang XB, Luo YJ (2007) Inspiration on ancient literature of ulcerative colitis. J New Chin Med 37:103–104

    Google Scholar 

  51. DongYX Li XC, Zhang EL (2004) Clinical curative effects of Chang Yan Kang oral liquid for ulcerative colitis. J Jilin Univ (med ed) 5:785–786

    Google Scholar 

  52. Hua R (2006) The experience of Professor Li Zhenhua for treatment ulcerative colitis. Henan Tradis Chin Med 26:17–18

    Google Scholar 

  53. Sun YY, Wu ST, Jiang DY (2008) The experience of Professor Zhang Qi for treatment Spleen-gastric disease. Shanxi Tradis Chin Med 24:6–8

    Google Scholar 

  54. Zhu LC (2001) The clinical experience and features of Professor Zhu Liangchun for treatment Chronic diarrhea and functional bowel disorder. Liaoning Tradis Chin Med 28:399–340

    Google Scholar 

  55. Joos S, Hahn EG, Brinkhaus B (2005) Use of complementary medicine: a survey in patients with inflammatory bowel disease. Z Allg Med 81:32

    Google Scholar 

  56. Macioca G (1994) The practice of Chinese medicine 1st ed. Churchill Livingstone, New York, pp 1–924

    Google Scholar 

  57. Chen Z (1995) Treatment of ulcerative colitis with acupuncture. J Tradis Chin Med 15:231–233

    CAS  Google Scholar 

  58. Yang C, Yan H (1999) Observation of the efficacy of acupuncture and moxibustion in 62 cases of chronic colitis. J Tradis Chin Med 19:111–114

    CAS  Google Scholar 

  59. Fang J (2010) Study progression of nursing on ulcerative colitis with traditional Chinese medicine. Mod J Integr Tradis Chin West Med 19:15

    CAS  Google Scholar 

  60. Zhao JL, Lian N, Yan QM, Zhang J, Guo MY (2002) Correlation between diet and recurrence of ulcerative colitis. J Chengdu Univ Tradis Chin Med 25:53–55

    Google Scholar 

  61. Xi JS (2006) Huang Qin Tang in the treatment of Ulcerative colitis. Beijing University of Chinese Medicine, Beijing, pp 65–79

    Google Scholar 

  62. Xiang DD (2009) KuiJie Ling decoction in the management of ulcerative colitis patient with damp heat brewing in the Intestines pattern. Heilongjiang University of Chinese Medicine, Haerbin, pp 37–47

    Google Scholar 

  63. Han CS (2010) Efficacy evaluation the protocol of TCM Combined therapy. Beijing University of Chinese medicine, Beijing, pp 1–80

    Google Scholar 

  64. Gong YP, Liu W, Ma GT, Hu HY, Xie JQ, Tang ZP, Hao WW, Bian H, Zhu LY, Wu HP, Zhu SL, Zhang YS (2007) Randomized control study of Qingchang suppository on ulcerative colitis. Acta UnivTradis Med Sinensis Pharmacol Shanghai 21:33–36

    Google Scholar 

  65. Li GD, Liu XJ, Zhou JH (2006) Yuan Xing Chang Anin the management of ulcerative colitis patient with damp heat brewing in the Intestines pattern: a randomized, double-blind, positive-controlled, multicenter study. 12nd National Congress of Coloproctology in Chinese Medicine, Jilin, pp 43–48

    Google Scholar 

  66. Zhang Y, Yang ZH (2005) Ulcerative colitis treated by acupuncture at Jiaji points (EX-B2) and tapping with plum-blossom needle at Sanjiaoshu (BL22) and Dachangshu (BL 25)—a report of 43 cases. J Tradis Chin Med 25:83–84

    Google Scholar 

  67. Zhang X (1998) 23 Cases of chronic nonspecific ulcerative colitis treated by acupuncture and moxibustion. J Tradis Chin Med 18:188–191

    CAS  Google Scholar 

  68. Ding H, Wang H, Zhang T, Tao Y (2009) Effects of ginger moxibustion on 30 patients with asdthenicsplenonephro-yang of ulcerative colitis. Acta Acad Med 18:509–511

    Google Scholar 

  69. Ma S (1999) Observation on the therapeutic effect of combined treatment of 60 cases of ulcerative colitis with acupuncture and moxibustion. World J Acup-Mox 9:24–26

    Google Scholar 

  70. Ma X, Sang X, Wu H, Shi Z, Liu H, Wang X (2007) Effects of acupuncture and moxibustion on intestinal mucosa morphology and expressions of GH and IGF-I in ulcerative colitis rats. Chin Arch Tradis Chin Med 25:1362–1365

    Google Scholar 

  71. Joos S, Wildau N, Kohnen R, Szecsenyi J, Schuppan D, Willich SN, Hahn EG, Brinkhaus B (2006) Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol 41:1056–1063

    PubMed  Google Scholar 

  72. Chen X, Ouyang Q, Hu RW, Li GD, Li XS (2005) An analysis of current treatment studies of ulcerative colitis from literatures of China. Sichuan Med 26:376–379

    CAS  Google Scholar 

  73. Ji J, Wu JJ (2005) Quality assessment of randomized controlled trials involving acupuncture for ulcerative colitis. J Hebei Tradis Chin Med Pharm 20:23–27

    Google Scholar 

  74. Wang JY, Han XH (2008) Quality assessment of randomized controlled trials involving Chinese herbal medicine for ulcerative colitis. J Liaoning Univ Tradis Chin Med 10:41–42

    Google Scholar 

  75. Yang AX, Jiang W (2006) Meta-analysis on clinical therapeutic effects of traditional Chinese medicine on ulcerative colitis. J Tradis Chin Med 47:283–284

    Google Scholar 

  76. Xiong J, Dong WJ, Song JS, Shang LS, Yuan A, Xu Y (2008) A systematic review of randomized clinical trials of Wu Mei Wan and its variation formula for ulcerative colitis. Jilin J Tradis Chin Med 28:296–299

    Google Scholar 

  77. Huang SG, Zhang HY, Huang SP (2010) Meta-analysis of ulcerative colitis treated with retention-enema of Chinese herb. Liaoning J Tradis Chin Med 37:1433–1435

    Google Scholar 

  78. Jiang T, Xia B, Li C (2006) Effects of retention enema with traditional Chinese medicines in the treatment of ulcerative colitis: a systematic appraisal. Herald Med 25:1016–1019

    Google Scholar 

  79. He M, Jiang J (2007) Chinese herbal medicines versus SASP for ulcerative colitis: a systematic review. Liaoning J Tradis Chin Med 34:1582–1583

    Google Scholar 

  80. Gan T, Wang Y, Jin SJ, Tian L (2010) Traditional Chinese medicinal herbs for induction of remission in ulcerative colitis (Protocol). http://www2.cochrane.org/reviews/en/protocol_911201092500231038.html (Accessed Jan 17, 2011)

  81. Mu JP, Wu HG, Zhang ZQ, Liu HR, Zhu Y, Shi Z, Wang XM (2007) Meta-analysis on acupuncture and moxibustion for treatment of ulcerative colitis. ZhongguoZhenjiu 27:687–690

    Google Scholar 

  82. Lee DH, Kim JI, Lee MS, Choi TY, Choi SM, Ernst E (2010) Moxibustion for ulcerative colitis: a systematic review and meta-analysis. BMC Gastroenterol 10:36

    PubMed  Google Scholar 

  83. Enck P (2007) Acupuncture treatment in gastrointestinal diseases: a systematic review. World J Gastroenterol 13:3417–3424

    Google Scholar 

  84. SFDA (2002) Guidance principles for clinical study of new Chinese materiamedica (Trial). China Medico-Pharmaceutical Sciences and Technology Publishing House, Beijing, pp 124–156

    Google Scholar 

  85. Li QG, Zhou XW, Shan ZW (2006) Guidelines for diagnosis and treatment of digestive disease in traditional Chinese medicine 1st ed. China Press of Traditional Chinese Medicine, Beijing, pp 1–219

    Google Scholar 

  86. Chen ZS, Wei BH, Zhang WD, Li DB (2005) Diagnostic and therapeutic scheme for ulcerative colitis with integrated Chinese and western medicine (protocol). Chin J Integr Tradis West Med Dig 13:133–136

    Google Scholar 

  87. Internal Medicine Branch of China Association of Chinese Medicine (2008) Guidelines for the diagnosis and treatment of common internal diseases in Chinese medicine. China Press of Traditional Chinese Medicine, Beijing, pp 1–309

    Google Scholar 

  88. Oxman AD, Cook DJ, Guyatt GH (1994) Users’ guides to the medical literature. VI. How to use an overview. JAMA 272:1367–1371

    PubMed  CAS  Google Scholar 

  89. Silagy CA, Middleton P, Hopewell S (2002) Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA 287:2831–2834

    PubMed  Google Scholar 

  90. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:w65–94

    PubMed  Google Scholar 

  91. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. www.cochrane-handbook.org. (Accessed Apr 6, 2012)

  92. Liu JP (2006) Clinical research methodology for evidence based Chinese medicine. People's Medical Publishing House, Beijing, pp 1–297

    Google Scholar 

  93. Tang JL, Zhan SY, Ernst E (1999) Review of randomised controlled trials of traditional Chinese medicine. BMJ 319:160–161

    PubMed  CAS  Google Scholar 

  94. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321:694–696

    PubMed  CAS  Google Scholar 

  95. Bian ZX, Li YP, Moher D, Dagenais S, Liu L, Wu TX, Miao JX, Kwan AK, Song L (2006) Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. J Chin Integr Med 4:120–129

    Google Scholar 

  96. Liang BL (2003) Progress of Chinese medicine research treatment in ulcerative colitis. Shaanxi Coll Tradis Chin Med 24:89–91

    Google Scholar 

  97. Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J (2010) Systematic review: the costs of ulcerative colitis in western countries. Aliment PharmacolTher 31:693–707

    CAS  Google Scholar 

  98. Lao YR (2010) Thinking about the key points in developing guidelines for Chinese and integrated medical clinical therapy. J Chin Integr Med 30:237–240

    Google Scholar 

  99. Liang WX (2009) Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Zhong Xi Yi Jie He XueBao 6:1–4

    CAS  Google Scholar 

  100. Chen KJ, Jiang YR (2009) Current status and problems in developing clinical guidelines for Chinese medicine and integrative medicine. J Chin Integr Med 7:301–305

    Google Scholar 

  101. Ke F, Yadav PK, Ju LZ (2012) Herbal medicine in the treatment of ulcerative colitis. Saudi J Gastroentrol 18:3–10

    Google Scholar 

  102. Gong Y, Zha Q, Li L, Liu Y et al. (2011) Efficacy and safety of Fufankushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double blinded and randomized study. J Ethnopharmacol E-pub ahead of print http://dx.doi.org/10.1016/j.jep.2011.08.057

  103. Costenbader KH, Gay S, Riquelme ME, Iacarrino L. Doria A. (2011) Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. E-pub ahead of print http://dx.doi.org/10.1016/j.autrev.2011.10.022

  104. Scarpa M, Stylianou E (2012) Epigenetics: concepts and relevance to IBD pathogenesis. Inflamm bowel dis. doi:10.1002/ibd22394

  105. Iborra M, Bernuzzi F, Inverzinni P, Danese S. (2012) MicroRNA in autoimmunity and inflammatory bowel disease: crucial regulators of immune response. Autoimmun Rev. E-pub ahead of print http://dx.doi.org/10.1016/j.autorev.2010.07.002

  106. Beaudet AL (2008) Epigenetics and complex human disease: is there a role in IBD. J Pediatric GastroenterolNutr 46(Suppl 1):E2

    Google Scholar 

  107. Logan I, Bowlus CL (2010) The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 9:A372–8

    PubMed  Google Scholar 

  108. Malik T, Mannon P (2012) Inflammatory bowel diseases: emerging therapies and promising molecular targets. Front Biosci (Schol Ed) 4:72–89

    Google Scholar 

  109. Corte C, Saxena P, Tattersall S, Selinger C, Leong R (2011) When to use biologic agents in inflammatory bowel disease. J GastroenterolHepatol. doi:10.1111/j.1440-1746.2011.07056.x

  110. Szekanecz Z, Szanto S, Szabo Z et al (2010) Biologics—beyond the joints. Autoimmun Rev 9:820–4

    PubMed  Google Scholar 

Download references

Acknowledgments

This research is supported in part by the Ministry of Sciences and Technology 2009ZX09502-019, National Science Foundation of China, No. 30825047 and 30902000.

Author information

Authors and Affiliations

  1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, No.16, Nanxiaojie, Dongzhimennei, Beijing, 100700, People’s Republic of China

    Chi Zhang, Miao Jiang & Aiping Lu

  2. School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong

    Aiping Lu

Authors
  1. Chi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aiping Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aiping Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, C., Jiang, M. & Lu, A. Considerations of Traditional Chinese Medicine as Adjunct Therapy in the Management of Ulcerative Colitis. Clinic Rev Allerg Immunol 44, 274–283 (2013). https://doi.org/10.1007/s12016-012-8328-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-012-8328-9

Keywords

Search

Navigation